These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7536513

  • 1. Effects of continuous stem cell factor administration on normal and erythropoietin-stimulated murine hemopoiesis: experimental results and model analysis.
    de Haan G, Dontje B, Nijhof W, Loeffler M.
    Stem Cells; 1995 Jan; 13(1):65-76. PubMed ID: 7536513
    [Abstract] [Full Text] [Related]

  • 2. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M.
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
    Wu DD, Nayar R, Keating A.
    Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543
    [Abstract] [Full Text] [Related]

  • 4. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H, Guilbert LJ, Janowska-Wieczorek A.
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 7. Hemopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation.
    Loeffler M, Bungart B, Goris H, Schmitz S, Nijhof W.
    Exp Hematol; 1989 Oct; 17(9):962-7. PubMed ID: 2776856
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 9. Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
    Goris H, Bungart B, Loeffler M, Schmitz S, Nijhof W.
    Exp Hematol; 1990 Jun; 18(5):400-7. PubMed ID: 2338129
    [Abstract] [Full Text] [Related]

  • 10. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP, Zsebo K, Hamburger AW.
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [Abstract] [Full Text] [Related]

  • 11. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 12. Hemopoiesis during thiamphenicol treatment. I. Stimulation of stem cells during eradication of intermediate cell stages.
    Goris H, Loeffler M, Bungart B, Schmitz S, Nijhof W.
    Exp Hematol; 1989 Oct; 17(9):957-61. PubMed ID: 2776855
    [Abstract] [Full Text] [Related]

  • 13. Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy.
    de Haan G, Engel C, Dontje B, Loeffler M, Nijhof W.
    Cancer Res; 1995 Jan 15; 55(2):324-9. PubMed ID: 7529132
    [Abstract] [Full Text] [Related]

  • 14. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003 Jan 15; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 15. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G, Bueren JA, Maganto G, Tuduri P, Guerrero A, Pivel JP, Real A.
    Stem Cells; 1995 Mar 15; 13(2):175-85. PubMed ID: 7540471
    [Abstract] [Full Text] [Related]

  • 16. Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11.
    Hassan HT, Biermann B, Zander AR.
    Eur Cytokine Netw; 1996 Mar 15; 7(2):129-36. PubMed ID: 8688490
    [Abstract] [Full Text] [Related]

  • 17. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
    LaIuppa JA, Papoutsakis ET, Miller WM.
    Exp Hematol; 1998 Aug 15; 26(9):835-43. PubMed ID: 9694504
    [Abstract] [Full Text] [Related]

  • 18. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
    Imamura M, Zhu X, Han M, Kobayashi M, Hashino S, Tanaka J, Kobayashi S, Kasai M, Asaka M.
    Exp Hematol; 1996 Sep 15; 24(11):1280-8. PubMed ID: 8862438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb 15; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.